VitaPCR™ Assays Enable Detection of the latest SARS-CoV-2 Variant Strain
Singapore, February 9, 2023 – Detection of the latest SARS-CoV-2 Variant Strain In response to the rise of new Covid-19 variants, Credo Diagnostics Biomedical Pte Ltd continues to ensure the effectiveness of our assays using BLASTn analysis. (with the oligonucleotide primers and probes of the assays involving SARS-CoV-2 detection) against the sequences listed in GISAID from September 1st, […]
